Epstein-Barr virus associated graft failure following heart/lung transplantation.
AuthorsEgan, J J
Stewart, J P
Hasleton, Philip S
Arrand, John R
Rahman, A N
Carroll, K B
Woodcock, A A
AffiliationNorth West Lung Centre, Wythenshawe Hospital, Manchester.
MetadataShow full item record
AbstractA case is described of late pulmonary graft failure in a heart/lung transplant recipient. The major characteristics were alveolar fibrosis and a restrictive physiological deficit. Epstein-Barr virus was implicated as an aetiological agent using immunohistochemical analysis and by a response to treatment with ganciclovir.
CitationEpstein-Barr virus associated graft failure following heart/lung transplantation. 1996, 51 (11):1160-2; discussion 1164-5 Thorax
- Epstein-Barr virus mediated graft rejection in heart transplant patients: implication of the cardiac cytoskeleton.
- Authors: LeBlanc MH, Boudriau S, Doyle D, Gagnon A, Beaudoin D, Coulombe D, Gleeton O, Kingma JG Jr, Boutet M
- Issue date: 1998 May
- A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events.
- Authors: Haque T, Thomas JA, Parratt R, Hunt BJ, Yacoub MH, Crawford DH
- Issue date: 1997 Oct 15
- Anorexia and failure to grow associated with Epstein-Barr virus infection.
- Authors: Simon MW
- Issue date: 1998 Jan
- Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation.
- Authors: Delone P, Corkill J, Jordan M, Krapiva P, Ghasemian R, Sasaki T, Light JA
- Issue date: 1995 Oct
- Breast cancer: a new Epstein-Barr virus-associated disease?
- Authors: Magrath I, Bhatia K
- Issue date: 1999 Aug 18